Introduction {#S1}
============

Fungal pathogenesis is a global public health issue, responsible for an estimated 1.5 million deaths each year largely in immune-suppressed individuals including those suffering from HIV-AIDS or tuberculosis, diabetics, cancer chemotherapy patients or immune suppressant-treated organ transplant recipients. Key to fungal virulence is the ability to colonize distinct host tissues and adapt to host environments with variations in pH, temperature, oxidants, and in the availability of nutrients and trace elements^[@R1]^. Trace elements such as zinc (Zn), iron (Fe), manganese (Mn) and copper (Cu) are essential for virtually all forms of life, where they perform structural, catalytic and signaling roles in processes such as transcription, protein degradation, respiration, reactive oxygen detoxification and a plethora of enzymatic activities^[@R2]^. At the host-microbial pathogen interface the availability of these trace elements that drive tissue colonization and virulence is often limited by a range of host processes that, together, are termed nutritional immunity^[@R3]^. For example, host proteins bind and sequester Fe, Zn and Mn from microbial pathogens, while host phagosomal membrane-associated metal transporters mobilize phagosomal Fe and Zn into the cytosol, further limiting their availability^[@R4],[@R5]^.

*Cryptococcus neoformans* is among the most devastating fungal pathogens, with over 1 million infections reported annually and a high mortality rate^[@R6]^. Ubiquitously found in the environment on plants, in decaying wood and in bird guano, the initial route of infection occurs by inhalation of desiccated yeast cells or aerosolized spores. Successful lung colonization causes pneumonia and allows dissemination through the bloodstream to the brain, where it causes lethal meningitis^[@R7]^. Notably, one feature of *C. neoformans* that allows successful colonization of multiple locations is its ability to effectively adapt to distinct host Cu environments^[@R8]-[@R11]^. Central to *C. neoformans* Cu homeostasis is the unique Cu-sensing transcription factor, Cuf1, which regulates transcriptional responses to both high Cu and Cu-limitation^[@R10],[@R11]^. Indeed, *cuf1∆* strains are hypo-virulent in murine infection models^[@R12]^.

Upon pulmonary infection alveolar macrophages engulf *C. neoformans* and accumulate and compartmentalize Cu within the phagosome, where it is used for intoxication of microbial pathogens^[@R13],[@R14]^. In response to these high Cu levels, the *C. neoformans* Cuf1 transcription factor activates genes encoding Cu-detoxifying metallothioneins (*MT1* and *MT2*) and a mitochondrial ABC transporter (*ATM1*) that functions in delivery of additional Cu-sensitive FeS clusters to the cytosol^[@R8],[@R10],[@R15]^. Activation of Cu detoxification pathways is required for successful *C. neoformans* lung colonization and virulence in murine pulmonary models of cryptococcosis^[@R8]^. In contrast, *C. neoformans* senses a Cu-limiting environment in the brain, where Cuf1 activates expression of two cell surface Cu^+^ importers, Ctr1 and Ctr4, that are conserved in their overall structure and function from fungi to humans^[@R9],[@R11]^. Both fungal and mammalian Cu^+^ importers are specific for Cu^+^ rather than Cu^2+^, and work in concert with coordinately regulated cell surface Cu^2+^ metallo-reductases^[@R10],[@R11],[@R16]^. However, the nature of the extracellular Cu source for high affinity Cu^+^ importers is not known. A *C. neoformans ctr1∆ ctr4∆* strain is Cu-deficient, fails to support Cu-dependent virulence traits such as Fe acquisition, oxidative stress resistance, melanin production and respiration and is hypo-virulent in murine meningitis models via direct intra-cerebral administration^[@R9],[@R11],[@R12]^.

A recent study merging RNAseq and ChIPseq data defined the Cuf1-dependent *C. neoformans* Cu-regulon in response to both elevated Cu and Cu-limitation^[@R10]^. Surprisingly, there is a plethora of genes with previously uncharacterized roles in Cu metabolism, the transcription which are directly regulated by Cuf1 in response to alterations in Cu availability. Here we describe *BIM1* (*CNAG_02775,* Uniprot ID J9VHN6), a gene that is strongly expressed under Cu-limitation that encodes a member of a new Lytic Polysaccharide Monooxygenase (LPMO)-like family. LPMO enzymes are secreted Cu-dependent enzymes that degrade recalcitrant carbohydrates through an oxidative mechanism^[@R17]^. We find that Bim1 binds Cu^2+^ in an atypical coordination environment for LPMOs that is reminiscent of the bacterial periplasmic Cu-binding protein CopC^[@R18]^, and unlike LPMOs, harbors a cell surface-tethering GPI anchor. Surprisingly, *bim1∆* cells are Cu-deficient and genetic and biochemical studies demonstrate that Bim1functions in cellular Cu uptake via the Ctr1 importer. Bim1 has a critical role in fungal meningitis, suggesting that *C. neoformans* has exploited this unusual Cu^2+^-binding cell surface bound a new LPMO-like family member to facilitate Cu acquisition in the brain of mammalian hosts to drive Cu-dependent virulence traits.

Results {#S2}
=======

Bim1 is expressed and required during Cu-limited growth {#S3}
-------------------------------------------------------

Many Cu-dependent processes are required for cryptococcal meningitis. As such, genes activated in environments with limited bioavailable Cu, such as the brain, may drive mechanisms required for adaptation for successful brain colonization. While genes encoding the high affinity Cu^+^ importers Ctr1 and Ctr4 are activated \~10- and \~400-fold, respectively in response to Cu-limitation by the Cu-specific chelator bathocuproine disulfonic acid (BCS), an additional transcript was the second most highly induced gene (*CNAG_02775*) under this condition^[@R10]^. The transcript encoding a protein termed Bim1 (BCS-inducible membrane protein), is elevated \~50-fold in *C. neoformans* cells grown under Cu-limiting conditions (BCS) compared to cells grown in the presence of CuSO~4~ ([Figure 1a](#F1){ref-type="fig"}). *BIM1* mRNA levels are also elevated during a genetically-induced Cu-deficiency, as shown by the increase in *BIM1* transcript levels in cells lacking the Ctr1 and Ctr4 Cu^+^ importers as compared to wild type cells grown in synthetic complete (SC) medium ([Figure 1b](#F1){ref-type="fig"}). The *BIM1* promoter harbors three conserved Cu-Responsive Elements (CuRE)^[@R10]^, critical for Cuf1 binding and activation under Cu-limiting conditions, beginning at positions -239, -268 and -516. Consistent with their presence, binding of the Cuf1 Cu-sensing transcription factor to the *BIM1* promoter is strongly induced under Cu-limiting conditions and expression of *BIM1* under these conditions is Cuf1-dependent ([Figure 1c](#F1){ref-type="fig"},[d](#F1){ref-type="fig"}).

Annotation of the Bim1 open reading frame as a hypothetical protein in available databases prompted a detailed analysis of the putative Bim1 protein sequence. These analyses revealed the presence of an amino-terminal 19 amino acid signal sequence for secretion, several putative sites for O- and N-linked glycosylation and a predicted cleavage site between amino acids 190 and 191 for the addition of a glycosylphosphatidyl inositol (GPI) anchor ([Supplementary Figure 1a](#SD1){ref-type="supplementary-material"}). Together, these features suggest that Bim1 encodes a 218 amino acid glycoprotein that is anchored to the plasma membrane, and/or to polysaccharides in the fungal cell wall. To gain further insights into Bim1 protein structure and function, the Bim1 sequence was analyzed by the I-TASSER structural prediction server^[@R19]^ against all structures in the PDB library. Surprisingly, the 10 best alignments corresponded to proteins known to be Lytic Polysaccharide Monooxygenases (LPMOs) ([Supplementary Table 1](#SD1){ref-type="supplementary-material"}). LPMOs are secreted Cu-dependent enzymes that degrade recalcitrant polysaccharides and are characterized by a mono-nuclear Cu^2+^ active site formed by an internal histidine sidechain, an amino-terminal histidine imidazole and the amino-terminal amine^[@R20]-[@R23]^. LPMOs were first found secreted by fungi and bacteria that obtain their energy from recalcitrant polysaccharides, including cellulose or chitin, but are more broadly distributed in biology^[@R17]^. LPMOs have high binding affinity for Cu, and catalysis through the solvent-exposed Cu^2+^ binding site is dependent on the presence of appropriate reductants and oxidants such as O~2~ or H~2~O~2~^[@R24]^.

To gain insights into the potential rationale for *C. neoformans* robustly activating expression of an LPMO-like protein under Cu-limiting conditions, *bim1∆* cells were generated and analyzed for growth during Cu deficiency. Interestingly, *bim1∆* cells exhibit a growth defect on SC medium in the presence of BCS that is complemented by returning wild type *BIM1* to the genome, and exacerbated on YPEG medium containing ethanol and glycerol as carbon sources that require Cu-dependent cytochrome oxidase function for their metabolism^[@R25]^ ([Supplementary Figure 1b](#SD1){ref-type="supplementary-material"}). The growth defect observed in *bim1*∆ cells on Cu deficient medium was not observed in other putative *C. neoformans* LPMOs ([cazy.org](http://cazy.org) database), such as the one encoded by *CNAG_03405* (Uniprot J9VQT7) ([Supplementary Figure 1c](#SD1){ref-type="supplementary-material"}). To test potential functional interactions between Bim1, Ctr1 and Ctr4 in Cu-limited growth, a series of isogenic single or combined mutants were generated and evaluated for growth under increasingly Cu-deficient conditions using BCS. As previously observed, *ctr1∆* or *ctr4∆* single mutants have modest Cu-deficiency growth phenotypes, but loss of both high affinity Cu^+^ importers results in a severe growth phenotype on SC and on YPEG medium ([Figure 2a](#F2){ref-type="fig"}). Moreover, *bim1∆ ctr4∆* cells phenocopied *ctr1∆ ctr4∆* Cu-deficiency growth defects, while *bim1∆ ctr1∆* cells resemble *bim1∆* mutants. These observations suggest that Bim1 and Ctr1 function in the same pathway to facilitate growth under Cu-limitation. Interestingly, the combined *bim1∆ ctr1∆ ctr4∆* mutant has a more severe Cu-deficiency growth phenotype, suggesting that Bim1 has additional functions independent of Ctr1 and Ctr4 to foster growth under Cu-limiting conditions.

To understand why *bim1∆* mutants grow poorly under Cu-limitation, *bim1∆* mutants were evaluated for biochemical hallmarks of Cu-deficiency^[@R10],[@R11],[@R26]-[@R29]^. In contrast to low levels of the *CTR4* transcript in Cu-replete wild type cells, *CTR4* transcript levels were strongly elevated in *bim1∆* cells, which was suppressed by exogenous Cu or by restoration of a wild type *BIM1* gene ([Figure 2b](#F2){ref-type="fig"}). Moreover, *bim1∆* cells showed a reduction in cell-associated Cu, in the enzymatic activity of Cu, Zn superoxide dismutase, in laccase-dependent melanin production ([Figure 2c](#F2){ref-type="fig"}-[d](#F2){ref-type="fig"}, [Supplementary Figure 1d](#SD1){ref-type="supplementary-material"}) and in the accumulation of cellular Fe, a well-established Cu-dependent process^[@R27],[@R28]^ ([Figure 2e](#F2){ref-type="fig"}). Given the genetic evidence that Bim1 functions in a Cu-accumulation pathway shared by Ctr1, Bim1 alleles were generated in which an HA-epitope was implanted within the Bim1 ORF starting at codon 36 or 92, to encode proteins (Bim1-HA) that functionally complement the Cu-deficiency *bim1∆* phenotype ([Supplementary Figure 2a](#SD1){ref-type="supplementary-material"}-[f](#SD1){ref-type="supplementary-material"}). Bim1-HA was immunoprecipitated from a *C. neoformans* strain expressing a functional Ctr1-FLAG epitope fusion and the precipitate analyzed with anti-FLAG antibody by immunoblotting ([Figure 2f](#F2){ref-type="fig"}). These experiments demonstrate that Bim1-HA forms a complex with Ctr1, either directly or indirectly, *in vivo*. Indeed, over-expression of Bim1-HA from the *GAL7* galactose-inducible promoter restored Cu-limited growth in a *cuf1∆* or a *cuf1∆ ctr4∆* strain, presumably due significant constitutive expression of *CTR1*^[@R11]^, but not in a *cuf1∆ ctr1∆* strain or a *ctr1∆ ctr4∆* strain ([Supplementary Figure 3ab](#SD1){ref-type="supplementary-material"}). Since Ctr1 transports Cu^+^ rather than Cu^2+,^ we hypothesized that perhaps the *C. neoformans* metallo-reductase Fre4, which is induced in Cu-limiting conditions by Cuf1^[@R10],[@R11]^, functions in complex with Ctr1 and Bim1 to liberate Cu^2+^ bound to the Bim1 Cu binding site^[@R10],[@R30]^. However, the protein Fre4-FLAG did not show an enrichment in a Bim1-HA immunoprecipitation experiment performed with a *C. neoformans* strain expressing a functional Fre4-FLAG epitope fusion ([Supplementary Figure 3c](#SD1){ref-type="supplementary-material"}). Taken together, these results demonstrate that *bim1∆* cells are defective in Cu accumulation and Cu-dependent activities in multiple cellular compartments, providing a basis for the Cu-deficiency growth defect. While more experiments are required to understand the precise mechanisms for Bim1 function in copper acquisition, these experimental data evidence that Bim1 likely operates via a Ctr1-dependent pathway for Cu uptake.

Bim1 localizes to the cell surface and coordinates Cu^2+^ {#S4}
---------------------------------------------------------

Bim1, related to LPMO enzymes at the primary sequence level, functions in *C. neoformans* Cu accumulation and is predicted to be a secreted, GPI-anchored Cu^2+^ binding protein. As fungal GPI anchors localize secreted proteins to both the plasma membrane and cell wall^[@R31]^, subcellular fractionation and indirect immunofluorescence microscopy experiments were used to localize Bim1-HA and Bim1-HA lacking the consensus GPI modification sequence (Bim1-HA-∆GPI) ([Figure 3 ab](#F3){ref-type="fig"}, [Supplementary Figure 4a](#SD1){ref-type="supplementary-material"}). Bim1-HA fractionated with the plasma membrane, was released from the cell wall after treatment with fungal cell wall lytic enzymes and also partially fractionated in the culture supernatant ([Figure 3a](#F3){ref-type="fig"}). While the Bim1-HA-∆GPI mutant protein was largely found in the culture supernatant ([Figure 3a](#F3){ref-type="fig"}), indirect immunofluorescence microscopy validated cell surface association of Bim1-HA in intact *C. neoformans* cells ([Figure 3b](#F3){ref-type="fig"}). Moreover, the Bim1-HA GPI anchoring sequence is required for complementation of the Cu-deficiency growth phenotype in a colony spot test on agar medium containing BCS ([Supplementary Figure 4b](#SD1){ref-type="supplementary-material"}). To test whether one role for the GPI anchor in Cu-limited growth may be to increase the cell surface concentration of Bim1, supernatants from *bim1∆* cells expressing either Bim1-HA, Bim1-HA-∆GPI, or empty vector were concentrated and incubated with *bim1∆* cells grown in SC medium in microtiter plates in the presence of increasing concentrations of BCS. Supernatants harboring Bim1-HA or Bim1-HA-∆GPI partially restored the growth of *bim1∆* cells in Cu-limiting conditions, with a trend toward better complementation by Bim1-HA-∆GPI supernatant, which contains higher concentrations of Bim1 ([Figure 3c](#F3){ref-type="fig"}).

Bim1 shows high sequence homology (36% identity) to novel GPI-anchored LPMO-like proteins from the fungi *Laetisaria arvalis* and *Laccaria bicolor*^[@R32]^ . Given the conservation with these proteins of the Cu^2+^-coordinating histidines and a GPI anchor, a structural model for Bim1 was generated based on the *La*X325 structure^[@R32]^ ([Figure 4a](#F4){ref-type="fig"}, [Supplementary Table 2](#SD1){ref-type="supplementary-material"}). The threaded structural model of Bim1 displays the putative histidine brace Cu^2+^- coordinating ligands found in all LPMOs (H20 and H65) and a potential aspartic acid Cu^2+^ ligand (D138) found within a glycine-rich loop of *La*X325 ([Figure 4b](#F4){ref-type="fig"}). To ascertain if histidine H20, H64,65 an aspartate D138 are important for Bim1-HA function, these residues were independently converted to alanine (H20A, H64,65A or D138A) or to serine (D138S) and expressed in *bim1∆* cells ([Supplementary Figure 4a](#SD1){ref-type="supplementary-material"}, [c](#SD1){ref-type="supplementary-material"}, [d](#SD1){ref-type="supplementary-material"}). The mutants were tested for complementation of *bim1∆* cells by growth on Cu limiting medium and melanin production ([Figure 4cd](#F4){ref-type="fig"}). Of note, H64 was also mutated as a potential Cu^2+^-ligand in Bim1, as these predictions come from a homology model rather than from an experimental structure. While wild type Bim1-HA complements *bim1∆* phenotypes, expression of neither the Bim1-HA H20A, H64,65A nor D138A/S mutants was able to restore growth on Cu-limiting medium. All Bim1-HA putative Cu binding site variants showed a hypo-melanization phenotype similar to that observed for the *bim1∆* strain. In all analyzed strains the hypo-melanization phenotype was restored to a similar level as that of the WT strain when 0.1 mM CuSO~4~ was added to the medium ([Figure 4d](#F4){ref-type="fig"}). In a *trans*-complementation assay, although the Bim1-HA H64,65A mutant expressed comparable levels of secreted protein to Bim1-HA, it failed to restore growth of the *bim1*∆ mutant in Cu-limiting conditions ([Supplementary Figure 4e](#SD1){ref-type="supplementary-material"}).

The histidine residues in Bim1 that are required for growth and melanin production under Cu deficient conditions correspond to the Cu^2+^-coordinating histidine brace conserved in LPMOs^[@R23]^. To ascertain whether Bim1 binds Cu^2+^, Bim1 was expressed in and purified from *Pichia pastoris* ([Supplementary Figure 5a](#SD1){ref-type="supplementary-material"}) and evaluated for Cu binding by Electron Paramagnetic Resonance spectroscopy (EPR), which detects Cu^2+^, but not Cu^+^. The EPR spectrum of Cu^2+^ alone was modified by titration of approximately equimolar Bim1, indicating that Bim1 binds Cu^2+^ with an estimated 1:1 stoichiometry ([Figure 4e](#F4){ref-type="fig"}). The EPR spectrum for the Cu^2+-^loaded Bim1 complex is axial with g~z~= 2.26 and a A~z~= 168 G (0.0177 cm^−1^) ([Supplementary Table 3](#SD1){ref-type="supplementary-material"}). These spectral features place the Cu^2+^-Bim1 complex within the Peisach-Blumberg classification of a type 2 copper centre^[@R33]^. The spin Hamiltonian parameters for Cu^2+^-Bim1 are comparable to LPMOs, although the coupling constant (A~z~/G = 168) is relatively high.

More definitive confirmation of the involvement of a putative histidine brace coordinating Cu^2+^ is evident from the analysis of X-ray Absorption Spectroscopy (XAS). The X-ray absorption edge energy, and lack of a Cu^+^ 1s→4p transition at 8984 eV, confirms the Cu^2+^ oxidation state^[@R34]^ ([Supplementary Figure 5b](#SD1){ref-type="supplementary-material"}). [Figure 4f](#F4){ref-type="fig"} shows the *k*^3^-weighted extended X-ray absorption fine structure (EXAFS) (black line) and corresponding Fourier transformation (FT) for a representative sample of Bim1. Both the k^3^-weighted EXAFS oscillations and the transformed data show the hallmark features of rigid-ring imidazole scattering from histidine ligands, a double hump at 4 Å^−1^ and multiple FT peaks between 2-4 Å, respectively^[@R35]^. The fit shown in [Figure 4f](#F4){ref-type="fig"} (red line, details reported in [Supplementary Figure 5c](#SD1){ref-type="supplementary-material"}) used multiple scattering pathways calculated from the crystallographic coordinates of a histidine brace Cu center from the LPMO from *H. jecorina* (PDB 5O2W)^[@R36]^ and requires two histidine ligands with 2.03 Å Cu-N. The identity of additional Cu^2+^ ligands is difficult to discern with XAS, but the fit requires an additional low Z ligand with a shorter distance (1.94 Å), an observation consistent with the possibility of a fourth unique ligand derived from aspartate oxygen. Single scattering fits are not shown but refine to an average ligand distance of 1.97 Å or can likewise be fit with two poorly resolved distances in the first shell (1.92 Å and 2.03 Å). Taken together, these studies demonstrate that Bim1 has a mononuclear Cu^2+^ center that, based on the *La*X325 structure, is modeled to utilize solvent accessible histidine ligands. Based on these data and the Bim1 mutagenesis results, the Bim1 His residues at positions H20 and H65, and D138 are likely the key residues that coordinate the Cu^2+^. These spectroscopic data provide important context for the proposed unique adaptation of the LPMO-like active site for Cu acquisition and virulence (see below). Given the similarity of Bim1 to *bona fide* LPMOs, Cu-Bim1 was assayed for catalytic activity on phosphoric acid swollen cellulose, a standard enzymatic assay in the LPMO field^[@R37]^. However, no cellulose cleavage products were detected ([Supplementary Figure 5d](#SD1){ref-type="supplementary-material"}). This observation does not exclude the possibility of Cu-Bim1 exhibiting activity on other yet unidentified substrates.

Bim1 role in Cu import is critical for fungal meningitis {#S5}
--------------------------------------------------------

While expression of Cu detoxification pathways is induced during pulmonary infection and critical for *C. neoformans* survival within macrophages, these components are dispensable in mouse models of cryptococcal meningitis^[@R8]^. Conversely, the *CTR1* and *CTR4* genes are transcriptionally activated by Cuf1 in the low bioavailable Cu environment of the brain, and *ctr1∆ ctr4∆* mutants, defective in Cu acquisition, are hypo-virulent in meningitis models^[@R9]^. Indeed, deletion of both Cu^+^ importers is required to observe a defect in mouse brain infection models. Given the similar Cu-deficiency phenotype of *ctr1∆ ctr4∆* cells and *bim1∆ ctr4∆* cells, experiments were conducted to ascertain whether Bim1 functions in the infectious niche of the brain. To bypass the lungs, retro-orbital mouse infections were conducted and mouse survival was assessed. The A/J inbred mouse strain infected with a *bim1∆ ctr4∆ C. neoformans* mutant survived nearly twice as long as mice infected with wild type cells or *bim1∆ ctr4∆* cells complemented with wild type *BIM1* ([Figure 5a](#F5){ref-type="fig"}). As A/J mice are inbred, a similar experiment was conducted in the genetically diverse outbred mouse strain, CD1. Similar results were obtained in the CD1 retro-orbital infection model, demonstrating that Bim1 plays an important role in virulence in genetically diverse mouse models of cryptococcal meningitis ([Figure 5b](#F5){ref-type="fig"}). Importantly, loss of both Cu acquisition pathways was required to observe this virulence defect, as loss of only Ctr4 ([Figure 5b](#F5){ref-type="fig"}) or Bim1 ([Supplementary Figure 6](#SD1){ref-type="supplementary-material"}) displayed virulence in retro-orbital infections that were similar to that of wild type *C. neoformans*. Consistent with a requirement for deployment of Cu detoxification mechanisms in the high Cu environment of the lung, and lack of *BIM1* expression in high Cu, inactivation of the Bim1 Cu acquisition pathway had no observable impact on virulence in an A/J mouse pulmonary infection model ([Figure 5c](#F5){ref-type="fig"}).

Discussion {#S6}
==========

The ability to rapidly adapt to changing environments is critical for colonization of infectious niches by microbial pathogens. During infection *C. neoformans* shifts from a Cu detoxification mode to actively acquiring Cu as it disseminates from the lungs to the brain^[@R8],[@R9],[@R12]^. This switch, orchestrated by the Cuf1 Cu-sensing transcription factor, is critical for colonization and pathology in both tissues^[@R10]-[@R12]^. While it is unclear how the brain, the most Cu-dependent organ on a tissue weight basis, limits pathogen access to Cu, *C. neoformans* senses a Cu-limiting environment, strongly activates expression of Ctr1 and Ctr4 and requires this Cu uptake machinery to drive a number of Cu-dependent virulence functions. What is striking from the current work is that under Cu limitation *BIM1* is among the top two genes robustly induced by Cuf1^[@R10]^. Bim1 binds Cu^2+^, has a critical function in Cu acquisition and the Bim1-Ctr1 pathway for Cu uptake plays a key role in cryptococcal meningitis.

What is the role played by Bim1 in Cu uptake? The Ctr1 and Ctr4 plasma membrane proteins are conserved in their overall topology and function from fungi to humans. These proteins support the permeation of Cu^+^ through membranes, generated through the action of cell surface metallo-reductases and coordinated via methionine thioether ligands through the membrane pore^[@R16],[@R38]^. Currently it is unclear how eukaryotic Cu^+^ transporters, or the Cu^2+^ metallo-reductases, obtain Cu from the extracellular environment. Recent work demonstrates that albumin and the multi-copper oxidase ceruloplasmin^[@R39]^, which exists as both a secreted form in the serum and attached to the surface of specific cells via a GPI linkage, are sources of extracellular Cu in mammals. While *in vitro* studies show that the amino-terminal peptide of human Ctr1 can collect Cu^2+^ from albumin^[@R40]^, ceruloplasmin can provide Cu to both Ctr1-dependent and Ctr1-independent Cu uptake mechanisms in cultured cells^[@R39]^. Additionally, some forms of CopC, a periplasmic protein found in bacteria, bind a single Cu^2+^ atom using His and Asp ligands^[@R18]^ similar to that identified in the *La*X325 protein^[@R32]^ and conserved in Bim1. Indirect evidence suggests that CopC could function in an analogous fashion to Bim1-Ctr1, in concert with the inner membrane protein CopD to import Cu^[@R18],[@R41]^.

Given the genetic and biochemical evidence supporting a role for Bim1 in Ctr1-mediumted Cu^+^ uptake, it is possible that Bim1 serves as an extracellular Cu ligand in a fashion similar to mammalian ceruloplasmin or bacterial CopC. In fact, mutation of the putative Bim1 Cu binding His and Asp residues, provoked by the Bim1 structural model, compromised the ability of Bim1 mutant proteins to complement the growth and melanization phenotypes of *bim1∆* growth on Cu limiting medium. We hypothesized that perhaps the *C. neoformans* Fre4 and Fre7 metallo-reductases, whose expression is also coordinately induced under Cu-limiting conditions by Cuf1^[@R10],[@R11]^, function together with Ctr1 and Bim1, to liberate the Cu^2+^ bound to the Bim1 Cu binding site^[@R10],[@R30]^. For example, the reduction of Bim1-bound Cu^2+^ to Cu^+^ could reduce binding affinity for Bim1 but increase affinity for Ctr1. We did not see an enrichment in Fre4 protein levels in a Bim1-HA co-immunoprecipitation experiment, however this negative result could be solely due to a potentially very transient interaction as a result of the highly solvent-exposed nature of the Cu^2+^ center in Bim1^[@R17]^. Moreover, as a *bim1∆ ctr1∆ ctr4∆* mutant has a Cu-deficiency phenotype more severe than a *ctr1∆ ctr4∆* mutant, Bim1 could also function with an as yet uncharacterized Cu importer, or through the oxidative degradation of the *C. neoformans* cell wall or capsule, both of which are reported to sequester metal ions^[@R7],[@R42],[@R43]^. While no obvious LPMO activity was detected in our experiments, current efforts are underway to ascertain if Bim1 has LPMO activity and to identify potential physiological substrates.

Bim1 is the first reported eukaryotic LPMO-like protein to function in Cu acquisition, thus expanding the repertoire of potential functions for this growing family of proteins. Interestingly, under Zn limiting conditions the pathogenic fungus *Candida albicans* induces expression and secretion of Pra1, a catalytically inactive member of a metalloprotease family which augments Zn uptake via interactions with the cell surface Zrt1 Zn importer^[@R44]^. Thus, organisms may generally exploit related enzyme family members that tightly and specifically bind metals to facilitate metal transfer, somewhat analogous to the structural resemblance between the intracellular CCS Cu chaperone for Cu, Zn superoxide dismutase (Sod1), which lacks enzymatic activity, and Sod1 itself^[@R29],[@R45]^. It is unclear why, like Pra1 in *C. albicans*, Bim1 is also found in the culture supernatant. Perhaps within the brain Bim1 that is shed in a spontaneous or regulated fashion acquires Cu from host Cu proteins and returns to the cell surface in a manner similar to siderophores. Based on results demonstrating Bim1 in the culture medium can complement the Cu-deficiency phenotype of *bim1∆* cells, perhaps the released Bim1 also functions in Cu acquisition in a cell non-autonomous manner, but the GPI anchor strongly improves this function.

While Bim1 plays a critical role in cryptococcal meningitis, at least in part through its role in Cu acquisition, it could play additional roles in *C. neoformans* during Cu limitation or as a means to invade and colonize host tissues in the brain by compromising host carbohydrate integrity. LPMO family members such as those from *Vibrio cholerae* and *Listeria monocytogenes* are virulence factors in mouse infection models^[@R46],[@R47]^. Also, an insect virus uses an LPMO for infection and dissemination and several plant pathogens activate expression of a large number of LPMO coding genes during their necrotrophic life cycle^[@R48]^. While the mechanisms might be unrelated, there is still much to be discovered on how LPMOs and LPMO-like proteins function in virulence during infection by microbial pathogens. In this regard, the *Cryptococcus* genome encodes for three other putative LPMOs from families AA9, AA11 and AA14 ([cazy.org](http://cazy.org) database), the expression of which is independent of Cu and Cuf1, but which could have virulence roles in plant or animal hosts.

Online Methods {#S7}
==============

Generation of *Cryptococcus neoformans* mutants {#S8}
-----------------------------------------------

DNA was introduced into *C. neoformans* by biolistic transformation. Yeast peptone dextrose (YPD) medium, supplemented with 1.5% agar and 100 μg ml-1 of nourseothricin (NAT), 200 μg ml-1 of neomycin (G418) or 200 μg ml-1 of hygromycin B (HYG) were used for colony selection after biolistic transformation. For Cu-import deficient mutants, YPD or YPD-sorbitol agar medium was supplemented with 40 μM CuSO~4~. Strains, plasmid descriptions and primers used are described in [Supplementary Dataset 1](#SD2){ref-type="supplementary-material"}. For cell growth assays *C. neoformans* cells were grown to stationary phase, diluted, plated with a pinner and incubated on untreated or treated SC-glucose, SC-galactose, or yeast peptone ethanol glycerol (YPEG) agar medium as indicated in figure legends.

RNA isolation and qRT-PCR {#S9}
-------------------------

*C. neoformans* overnight cultures grown in synthetic complete (SC) medium (MP Biomedicals) or YPEG medium, as indicated in figure legends, were diluted to OD~600~ of 0.3, grown for 2 h and treated as indicated. *C. neoformans* mRNA isolation and expression analysis was performed as previously described^[@R10]^. Primers used for *BIM1*, *CTR4* and *ACT1* qRT-PCR are described in [Supplementary Dataset 1](#SD2){ref-type="supplementary-material"}.

Chromatin Immunoprecipitation {#S10}
-----------------------------

Overnight cultures of *C. neoformans cuf1*∆ cells complemented with Cuf1-FLAG ([Supplementary Dataset 1](#SD2){ref-type="supplementary-material"}) were diluted to OD~600~ of 0.2, grown for 3 h and then treated with 1 mM Cu or 1 mM BCS for 3 h. ChIP-PCR analysis was performed as previously described^[@R10]^. Specific primers used for detecting the *BIM1* and *TUB1* promoters by qPCR are described in [Supplementary Dataset 1](#SD2){ref-type="supplementary-material"}.

*In silico* analysis of the *BIM1*-encoded open reading frame {#S11}
-------------------------------------------------------------

Bioinformatic analysis of CURE sites was performed with the motif-based sequence analysis tool provided by the Meme Suite platform^[@R49]^. The *BIM1* coding sequence was analysed in SignalP 4.1^[@R50]^, big-PI predictor^[@R51]^, NetNGlyc 1.0 (<http://www.cbs.dtu.dk/services/NetNGlyc/>), NetOGlyc 4.0^[@R52]^ and I-TASSER^[@R19]^ for predictions of amino-terminal signal peptide, GPI anchoring, N- and O-glycosylation and protein structure, respectively.

Inductively coupled plasma mass spectrometry (ICP-MS) {#S12}
-----------------------------------------------------

*C. neoformans* cells were grown in YPEG medium to stationary phase, diluted to OD~600~ of 0.2 and then grown for 3 h. Cells were harvested, pellets washed once with 1xPBS containing 5 mM EDTA, once with 1xPBS and twice with ultra-pure water. Pellets were digested by boiling overnight with 200 μl 100% HNO~3~. ICP-MS analyses were performed by the Environmental and Agricultural Testing Service, Department of Soil Science, North Carolina State University, Raleigh. Metal concentrations were obtained according to a standard curve and normalization between samples was performed by dividing the metal concentration of each sample to its phosphorous concentration, also determined by ICP-MS.

Enzyme activity assays {#S13}
----------------------

*C. neoformans* cells were grown in the indicated medium to stationary phase, diluted to OD~600~ of 0.2 and then grown for 3 h. Cells were pelleted, washed once with 1xPBS and protein extracts were obtained at 4°C with 50 mM HEPES-KOH pH 7.5, 140 mM NaCl, 1% Triton X-100, 1 mM EDTA and fungal specific protease inhibitors (Sigma). Cu, Zn SOD activity measurements were performed according to the SOD1 assay kit (Sigma). Data was normalized to protein concentration, determined with the Pierce BCA assay (Thermo Fisher). For melanin assays *C. neoformans* cells were grown in SC medium to stationary phase, diluted to an OD~600~ of 2.5 and plated with a pinner on L-3,4-dihydroxyphenylalanine (L-DOPA) agar medium (7.6 mM L-asparagine monohydrate, 5.6 mM glucose, 22 mM KH~2~PO~4~, 1 mM MgSO~4~.7H~2~O, 0.5 mM L-DOPA, 0.3 μM thiamine-HCl, 20 nM biotin, pH 5.6). L-DOPA plates were incubated at 30°C for 2 days in the dark and photographed.

*C. neoformans* subcellular fractionation {#S14}
-----------------------------------------

Protein analysis of *Cryptococcus* subcellular fractions and culture supernatant was performed as previously described with minor modifications^[@R53]^. *C. neoformans* cells were grown in YPD agar lawns for 72 h, cells harvested and resuspended in secretion buffer (10 mM imidazole, 2% glucose, pH 5.0) (ratio of 5 ml/plate) and incubated at 30°C for 17 h with shaking. After incubation, cells were collected by centrifugation and supernatants kept for protein content analysis (secreted fraction). Pelleted cells were washed once with 1xPBS, once with morpholineethanesulfonic (MES) acid-buffered saline (MBS; 25 mM MES, 150 mM NaCl, 2 mM EDTA, pH 6.5), resuspended in 500 μl of ice-cold MBS containing 0.1% (vol/vol) Triton X-100 and fungal specific protease inhibitors (Sigma) and lysed by bead beating for 6 cycles of 1 min at 4°C. Lysates were centrifuged at 3,500 g for 10 min at 4°C, supernatants were collected, set on ice and pellets resuspended in 1 ml of the same buffer and further disrupted by probe sonication for 5 cycles of 10 s ON, 10 s OFF, with at an output of 4. Samples were centrifuged at 3,500 g for 10 min at 4°C, and supernatants combined with those from the previous spin. Pellets from this spin, which contain the cell wall fraction, were washed twice with 1xPBS (with 1 min centrifugation after each wash), once for 1 h with 1% SDS at 37 °C with shaking, twice with 1 M NaCl and once with 1xPBS. Washed pellets were split into two tubes, one resuspended in 1 ml water and 100x fungal specific protease inhibitors (Sigma), the other resuspended in 1 ml of lytic enzymes from Trichoderma harziarum (Sigma) (prepared at 10 mg/ml in water and 100x fungal specific protease inhibitors). Both tubes were incubated for 1 h at 37 °C, and the supernatant, containing cell-wall released proteins, was collected by centrifugation (14,000 g, 15 min, 4°C). Those supernatants previously set aside on ice, were ultra-centrifuged at 135,000 g for 1 h at 4 °C to separate the pellet (crude membranes) from the supernatant (cell associated fraction). Approximately 100 μl of crude membranes per strain were resuspended in 200 μl of ice-cold 50 mM Tris-HCl pH 7.5, 0.5 mM EDTA and fungal specific protease inhibitors. Resuspensions were probe sonicated for 3 cycles of 5 seconds ON and OFF, with an output of 4. 120 μl of TritonX-114 were added to the samples mixed and chilled on ice for 1 h. After 1h, samples were centrifuged at 14,000 rpm for 10 min at 4 °C in a microcentrifuge to remove insoluble debris. The supernatant was heated to 37 °C for 30 min to achieve phase separation. The aqueous phase was removed from the lower (detergent) phase by centrifugation for 5 min at 14,000 rpm in a microcentrifuge. To remove residual aqueous material, the detergent phase was washed three times by mixing the detergent phase with 200 μl of 50 mM Tris-HCl pH 7.5, 0.5 mM EDTA followed by 5 min at 14,000 rpm centrifugation and supernatant removal. For the membrane partition fraction, proteins were recovered by trichloroacetic acid (TCA) precipitation addition to a final 10% concentration, followed by 20 min centrifugation at 14,000 rpm at 4 °C. Pelleted proteins were washed once with ice-cold acetone and resuspended in 50 μl of 100 mM Tris-HCl, pH 8.3, 1 mM EDTA, 1% SDS. Proteins from the different fractions were analyzed by immunoblotting with anti-HA (Y-11, polyclonal, Santa Cruz), anti-H3 (D1H2, polyclonal, Cell Signaling) and anti-Cda2 (a generous gift from J.K. Lodge) antibodies.

Bim1 trans-complementation assays {#S15}
---------------------------------

*C. neoformans* strains *bim1*∆ (DTY1000), *bim1*∆ complemented with either Bim1-HA (DTY1005), Bim1-HA (∆GPI) (DTY1007) and Bim1-HA H64A H65A (DTY1009) were grown in YPD agar lawns for 72 h (2 plates per strain). Cells were harvested and resuspended in secretion buffer (10 mM imidazole, 2% glucose, pH 5.0) (ratio of 5 ml/plate) and incubated at 30 °C for 17 h with shaking. After incubation, cells were pelleted and supernatants from 10 ml of overnight secretions (2 plates) were filtrated through 0.45 μm pore size filters (to facilitate supernatant concentration) and concentrated to approximately 200 μl (\~ 6 μg/μl of total protein) in Amicon® Ultra 15 ml centrifugal filter devices (Millipore) with a 10,000 NMWL. After supernatant concentration, protein from all strains was normalized to 5 μg/μl in 200 μl of medium. 15 μl were used for immunoblotting analysis and the rest was diluted into 7 ml of SC medium. The 7 ml of medium, containing secreted proteins (including secreted Bim1-HA or mutants of Bim1-HA), were filter sterilized using 0.2 μm pore size filters. *C. neoformans bim1*∆ cells grown overnight in SC medium were diluted to an OD~600~ of 0.004 in 2 ml of each of the filter sterilized SC medium containing the secreted proteins from the different strains. Quantitative liquid growth assays were performed as described below.

Liquid growth assays {#S16}
--------------------

To perform growth analysis in liquid cultures, all wells of a 96-well plate were filled with 50 μl of SC medium. With a multichannel pipette, 50 μl of SC medium containing 20 mM BCS were added to each well of column number 12 in the plate and mixed with the previously added medium. With a multichannel pipette, 50 μl of SC medium from column number 12 (with 10 mM BCS) were transferred each well of column number 11, and this process was repeated until reaching column number 3 (column 1 was kept as a blank, and column 2 was the untreated control). After filling the plate with medium containing BCS, three rows of wells from column 1 to column 12 (2 technical replicates per experiment) were filled with 50 μl of the analyzed cells previously diluted to OD~600~ of 0.004 in SC medium. Plates were covered with a semipermeable membrane and incubated at 30 °C with shaking at 900 rpm in a Finstruments shaker instrument. Growth graphs were generated by plotting the OD~600~ readings *versus* the compound concentrations at the 48 h time point. Three biological replicates were performed.

Immunoprecipitation {#S17}
-------------------

*C. neoformans* cells were grown in 25 ml precultures overnight in SC medium at 30°C. Precultures were diluted to OD~600~ of 0.3 in 100 ml of SC, grown for 2 h and treated with 0.5 mM BCS for 3 hours. Formaldehyde (crosslinker) was added to the medium at 0.8% final concentration followed by 7 min incubation at room temperature with occasional shaking. After incubation, crosslinking was quenched with glycine at a final concentration of 125 mM followed by 5 min incubation at room temperature. Cells were collected by centrifugation and washed once in 125 mM glycine in 1xPBS and twice with 1 x PBS. Cell pellets were then resuspended in 450 μl of lysis buffer (50 mM HEPES-KOH, pH 7.5, 150 mM NaCl, 5% glycerol, 1% NP-40, 0.5% foscholine-14 and protease inhibitors) and lysed by 6 cycles of 1 min ON, 1 min OFF bead beating. Cell debris was separated from lysates by 5 min centrifugation at 14,000 rpm at 4 °C. Protein concentrations were measured in lysates by the Pierce BCA protein concentration kit (Thermo Fisher) and normalized between the strains. A fraction of the protein lysates was kept frozen and loaded as input for the immunoblotting analysis, and the rest of the lysates were incubated overnight with rocking with 30 μl of anti-HA agarose resin slurry (Pierce), prewashed once with 500 μl TBST. After overnight incubation, the resin was washed twice with 1% Triton-X100, once with TBST and once with 50 mM ammonium bicarbonate. Proteins were eluted from the beads by 10 min boiling with 50 μl of 100 mM Tris-HCl, pH 8.3, 1 mM EDTA, 1% SDS. Input and eluted fractions were analyzed by immunoblotting with anti-FLAG (monoclonal, HRP-conjugated, Sigma) and anti-HA (Y-11, polyclonal, Santa Cruz) antibodies.

Mouse infection experiments {#S18}
---------------------------

Inbred female A/J mice (Jackson Laboratories) and CD1 mice (Charles River Laboratories), aged 4 to 6 weeks, were used for virulence experiments. Purchased mice were acclimated for one week. For infections all *C. neoformans* strains were grown in SC medium overnight and washed 3 times with sterile 1 x PBS. Infections were performed intranasally or retro-orbitally with *C. neoformans* inocula as indicated in figure legends. Mouse infection experiments were performed in compliance with all ethical regulations. The mice protocol was revised and approved by the Duke University Institutional Animal Care and Use Committee (DUIACUC). Protocol approved documents were signed by Herman Staats, PhD (Chair, IACUC). Experimental endpoints were considered a 15 % reduction in body weight.

Protein extraction and immunoblotting {#S19}
-------------------------------------

TCA-precipitated protein extracts were used to analyze Bim1-HA expression in wild type Bim1-HA or Bim1-HA mutants. For all figures, except [Supplementary Figure 4c](#SD1){ref-type="supplementary-material"}, overnight cultures of *C. neoformans* cells were diluted to an OD~600~ of 0.3 in 5 ml of fresh SC medium, left untreated or treated with the indicated concentration of BCS for the indicated times. For the data in [Supplementary Figure 4c](#SD1){ref-type="supplementary-material"}, overnight cultures of *C. neoformans* cells were diluted to an OD~600~ of 0.3 and grown to an OD~600~ of 3. After each time point TCA was added to a final concentration of 10%, cells pelleted, collected with 20% TCA and further processed as described. Supernatants from experiment in [Supplementary Figure 4c](#SD1){ref-type="supplementary-material"} were directly treated with loading buffer before SDS-PAGE and immunoblotting analysis. TCA protein extracts and supernatants were analyzed by immunoblotting with anti-HA (Y-11, polyclonal, Santa Cruz or SG-77, polyclonal, Invitrogen) and anti-H3 (D1H2, polyclonal, Cell Signaling) antibodies.

Indirect immunofluorescence {#S20}
---------------------------

*C. neoformans* strains WT (DTY758) and *bim1*∆ complemented with Bim1-HA (DTY1006) were grown in SC to stationary phase. Precultures were then diluted to OD~600~ of 0.3 in 25 ml of SC medium. Cells were treated with 0.5 mM BCS and grown for 3 hours. After treatment, formaldehyde was added to a 3.7% final concentration followed by 20 min incubation at room temperature with shaking. After incubation, crosslinking was quenched with glycine at a final concentration of 125 mM followed by 5 min incubation at room temperature. Cells were collected by centrifugation and washed once in 125 mM glycine in 1xPBS and twice with 1 x PBS. Pellets were resuspended in 2 ml of 100 mM Tris-HCl pH 9.5 containing 10 mM DTT and incubated at 30°C for 20 min with 70 rpm shaking. Cells were pelleted at 3000 g during 5 min and pellets were resuspended in 5.2 ml of resuspension buffer (0.1 M sodium citrate, 1.1 M sorbitol pH 5.5) containing 10 mg/ml of lytic enzymes (Sigma, L1412) and halt protease inhibitors (Roche) and incubated for 2 h at 30°C with 70 rpm shaking. After incubation, spheroplasts were pelleted by centrifugation (8 min at 2200 g) and rinsed once with 10 ml of ice-cold resuspension buffer. Spheroplasts were collected by centrifugation (8 min at 2200 g) and resuspended in 2 ml of incubation buffer (10 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% BSA and 0.02% sodium azide). 100 μl aliquots were incubated over night with 1:10 dilution of anti-HA (Y-11, polyclonal, Santa Cruz) antibody at 4°C. After the incubation, spheroplasts were washed three times with PBS containing 1% BSA. Spheroplasts were then resuspended in 100 μl PBS containing 1% BSA and 2 μg/ml of secondary antibody Alexa Fluor 594 and incubated at room temperature for 1 hour in the dark with 70 rpm shaking. The secondary antibody was three times with PBS containing 1% BSA and cells were mounted in a slide containing a 2% low melting point agarose pad prepared with SC medium. Slides were sealed with nail polish and cells observed with a Zeiss Axio Imager Microscope.

Homology modelling of Bim1 {#S21}
--------------------------

A homology model of Bim1 was created using the one to one threading option in Phyre2^[@R54]^, based on the tetragonal crystal structure of *La*X325^[@R32]^, PDB code 6IBJ. Bim1 and *La*X325 share 36% sequence identity. Local alignment and secondary structure scoring (with a weight of 0.1) were used for producing a model with 100% Phyre2 confidence (this just indicates the confidence that the two sequences aligned truly represent two homologous proteins). Phyre2 aligns Hidden Markov Models (HMMs) of query and target. Based on this alignment, Phyre2 builds a crude backbone model based on the template, then fills missing loops using a fragment database from known structures. Finally, side chains were built in their most probable rotamer while avoiding clashes. In order to improve the geometry of the model, two Ramachandran outliers were corrected in COOT^[@R55]^, and 20 cycles of structure idealization carried out in REFMAC5^[@R56]^ after adding coordinates for Cu^2+^ based on the template structure. The final model had good geometry as evaluated using the Molprobity server^[@R57]^. The Cα RMSD between the Bim1 model and the template was 0.679 Å.

Expression of Bim1 in *Pichia pastoris* {#S22}
---------------------------------------

RNA from an exponentially growing *C. neoformans* cell culture was isolated with the Qiagen RNeasy mini kit, and DNAse treated with the turbo-DNA free kit (Roche). cDNA was synthesized with the SuperScript® III First Strand Synthesis System (Invitrogen), using oligo (dT) nucleotides and following the manufacturer instructions. A PCR with OLSG-120 and OLSG-192 on C. neoformans cDNA was performed and the PCR product was EcoRI/NotI digested and cloned into EcoRI/NotI digested pPIC3.5k (DTP1932) (Invitrogen). The reverse primer (OLSG-192) was designed to generate the expression of Bim1 attached to a TEV protease cleaving site and a 6 Histidine tag ([Supplementary Dataset 1](#SD2){ref-type="supplementary-material"}). The resulting plasmid, was digested with SalI and transformed by electroporation in the *P. pastoris* KM71 strain following the Pichia expression kit (Invitrogen) electroporation and colony selection protocols. A *P. pastoris* 25 ml culture of a Bim1-TEV-6His expressing cells (DTY1022) were grown until saturation in pH 6 buffered BMGY medium. This preculture was diluted into a 1 l of pH 6 buffered BMGY medium and grown overnight. Cells were pelleted and transferred to 4 baffled flasks, with 1.6 l each of pH 6 buffered BMMY medium, containing 1% methanol. Buffered BMGY and BMMY medium were prepared as described in the Pichia expression kit (Invitrogen). Bim1-TEV-6xHis expression was induced for 4 days by adding 1% methanol to the cultures once a day (or 0.5% methanol twice a day, with no difference in the outcome). At day 4 cells were harvested and cleared supernatants were used for protein purification. 40 ml of nickel-nitrilotriacetic acid-agarose (Ni-NTA) slurry were distributed into three 2.5 × 20 cm glass chromatography columns (BioRad). The Ni-NTA slurry was washed with 50 ml of a buffer containing 50 mM phosphate buffer pH 8, 300 mM NaCl and 10 mM imidazole. The washed beads were added to three different flasks, each containing 2.1 l of the collected supernatants. The supernatants were kept shaking with a magnetic stirrer at room temperature for 1 h. After 1 h, supernatants and Ni-NTA beads were poured through three glass chromatography columns (as above) and then washed with 50 ml of washing buffer (50 mM sodium phosphate, pH 8, 300 mM NaCl and 40 mM imidazole). For eluting the protein from the beads, beads were incubated 1 × 15 min with elution buffer (50 mM sodium phosphate pH 8, 300 mM NaCl and 40 mM imidazole) followed by other 2 × 5 min incubations with elution buffer. The eluted fractions were collected by gravity flow in all cases. In order to remove the Histidine tag, the elution buffer was exchanged to TEV cleavage buffer (50 mM Tris-HCl pH 8, 150 mM NaCl) until reaching an imidazole concentration below 0.25 mM, by using Amicon® Ultra 15 ml centrifugal filter devices (Millipore) with a 10,000 NMWL. After buffer exchange, the protein was diluted to a 1 mg/ml, checked using the Pierce BCA protein concentration kit (Thermo Fisher), and incubated for 17 h with 0.5 U of Histidine tagged turbo TEV protease (Eton Bioscience) per μg of purified Bim1 in TEV cleavage buffer containing 1 mM final concentration of DTT. After the 17 h incubation, the protein-turbo TEV protease mix was further diluted to buffer concentrations of 50 mM Tris-HCl, pH 8, 150 mM NaCl, 0.2 mM DTT and 10 mM imidazole. This diluted sample was incubated for 1 h with previously washed Ni-NTA beads. After 1 h, the flow through from the beads, containing purified Bim1 without the His tag, was collected by gravity flow (the turboTEV protease and the removed His-tag from Bim1 remained stacked to the Ni-NTA beads). In order to N-deglycosylate Bim1, the previously collected flow through was buffer exchanged to 50 mM sodium acetate, pH 6 by using Amicon Ultra 15 ml centrifugal devices, as described above. Bim1 was diluted to 1 mg/ml in 50 mM sodium acetate buffer and incubated for 17 h at 25 °C with 0.02 U of Endo H (NEB) per μg of Bim1 protein. Immediately after deglycosylation, Bim1 was further purified by size exclusion chromatography on a Superdex-200 column (GE Healthcare) at a constant flow rate of 1.3 ml/min in 50 mM sodium acetate buffer pH 6 using an Akta FPLC (GE Healthcare) system. Fractions containing pure Bim1 were collected, pooled and concentrated.

X-band Electron Paramagnetic Resonance (EPR) and X-ray Absorption Spectroscopy (XAS) {#S23}
------------------------------------------------------------------------------------

Purified Bim1 was used for X-band EPR analysis and X-ray absorption spectroscopy. EPR data were acquired using quartz EPR tubes and a Bruker EMX spectrophotometer with the following parameters; frequency 9.44 GHz, modulation 0.4 mT, center field 3400, sweep width 3000, sweep time 30 s, receiver gain 30 dB, microwave power 10.02 mW. Samples contained a 0.4 mM solution of CuSO~4~ in the presence or absence of 0.5 mM Bim1 at pH 6.0 (50 mM sodium acetate, 30% (v/v) glycerol) and spectra were collected at liquid nitrogen temperature. Cu^2+^ stock solutions were prepared by dissolving copper sulfate (CuSO~4~, Sigma) in nano-pure water and standardized by EDTA titration in an ammonium buffer to a murexide end point. X-ray absorption data on two replicate samples of the *C. neoformans* lytic polysaccharide monooxygenase homologue Bim1 were measured at the Stanford Synchrotron Radiation Laboratory on beamline 9-3. Bim1 protein samples were 0.4 mM in Cu and prepared in 50 mM sodium acetate buffer at pH 6 with 30% glycerol added as a cryoprotectant. Samples were loaded into a lucite sample cell wrapped in Kapton tape before flash freezing in liquid nitrogen. The SSRL storage ring was operating at 3 GeV with a maximum current of 500 mA. Beamline 9-3 uses a Rh-coated focusing mirror for harmonic rejection and was equipped with Si(220) monochromator crystals for energy selection. Copper fluorescence was detected with a Canberra 100- or 30-element germanium detector. Samples were maintained at 8K in an Oxford liquid helium continuous flow cryostat. A 6-micron nickel filter with a Soller-slit assembly was placed between the cryostat window and the detector to reduce scatter. The energy was calibrated by simultaneously measuring the edge spectrum of a copper foil, with the energy of the rising inflection point being assigned as 8980.3 eV. Spectra represent the average of 4 scans for the 100 element detector data (each scan on a fresh area of the sample) and 11 scans for the 30 element detector data (each set of 2-3 scans on a fresh area of the sample). The data were fit over a k range of 1-12.8 Å-1 without the use of any Fourier filtering or smoothing. Data were analyzed using EXAFSPAK (<http://www-ssrl.slac.stanford.edu/exafspak.html>) interfaced with FEFF7.0^[@R58]^ for theoretical phase and amplitude functions. Multiple scattering pathways were calculated using the coordinates of a histidine brace active site in *H. jecorina* (PDB 5O2W) as shown in [Supplementary Figure 5c](#SD1){ref-type="supplementary-material"}^[@R36]^. Double and single scattering paths less than 4.5 Å with three or two legs were included in the fits. This scattering unit was then used as the basis for modeling the data allowing R and σ2 to vary, where σ2 is the Debye Waller factor, the mean square deviation in R. Coordination numbers for histidine ring atoms were scaled by two to model a second histidine. ∆E^0^ refined to −11 eV for the primary Cu-N interaction in the Histidine ring but was held constant in the other paths. The goodness of fit was evaluated using the F factor (a least-square deviation between data and fit) corrected for the number of variable parameters used in the fit (<http://www-ssrl.slac.stanford.edu/exafspak.html>). The Cu-ligand distance, R, and the Debye-Waller factor were freely varied for the primary Cu-N interaction but the other pathways were linked to maintain the rigid model system's geometry. Metric parameters for the representative fit shown in [Figure 4f](#F4){ref-type="fig"} are given in [Supplementary Figure 5c](#SD1){ref-type="supplementary-material"}.

Bim1 activity {#S24}
-------------

Bim1 activity was tested in a cellulose saccharification assay by comparing its activity to that of the archetypical *Thermoascus aurantiacus* cellulolytic LPMO^[@R59]^. Briefly, 2 mL microcentrifuge tubes were filled with 0.5mL 0.3% phosphoric acid swollen cellulose, 25 mM citrate phosphate buffer pH 6.0, 2mM ascorbic acid and 12μM CuCl~2~. The assay was started by adding either 10μM Bim1 or 10μM *Ta*AA9A or no-enzyme as a control. Samples were incubated for 50 hours in a thermomixer at 40°C and shacked at 550 rpm. The samples were clarified on a 0.45 μm filter and subjected to anion exchange chromatography^[@R60]^.

Statistical analysis {#S25}
--------------------

For all data error bars represent statistical errors of the means (SEM) of results from a number of biological replicates (N), as indicated in figure legends. Before statistical analysis was conducted, data from all experiments was log transformed for comparison of proportions. Statistical analysis was performed with GraphPad Prism software v7. The statistical tests chosen for each experiment and their results (i.e. P values) are indicated in figure legends. Asterisks in figures correspond to statistical significance as follows: \*\*\*\*, P \< 0.0001; \*\*\*, P = 0.0001 to P \< 0.001; \*\*, P = 0.001 to P \< 0.01; \*, P = 0.01 to P \< 0.05; ns (not significant), P \> 0.05.
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![*C. neoformans BIM1* transcription is induced in Cu deficiency in a Cuf1-dependent manner.\
(**a**) Mean (± SEM) values of *BIM1* transcript levels by qRT-PCR analysis in *C. neoformans* wild-type H99 (DTY758) cells treated with BCS or CuSO~4~. n=3 biologically independent samples (3 technical replicates each), 2-tailed t-test, t=16.46, d.f.=4, P\<0.0001 (\*). (**b**) qRT-PCR analysis of mean (± SEM) relative *BIM1* transcript levels in *C. neoformans* wild-type H99 (DTY758), *ctr1*∆ (DTY765), *ctr4*∆ (DTY763), and *ctr1*∆ *ctr4*∆ (DTY759) cells grown in SC medium. n=3 biologically independent samples (3 technical replicates each), 1-way ANOVA, F=3.6, d.f.=3, P\<0.06, Fisher's LSD test was performed for multiple comparisons. WT vs *ctr1*∆ *ctr4*∆ P=0.0275 (\*), *ctr1*∆ *vs ctr1*∆ *ctr4*∆ P=0.0291 (\*). (**c**) *cuf1*∆ cells complemented with Cuf1-FLAG (DTY758) were grown in either CuSO~4~ or BCS and the occupancy of Cuf1-FLAG protein on the *BIM1* promoter was analyzed by ChIP-qPCR experiments. Mean (± SEM) fold enrichment in the immunoprecipitation relative to input material was calculated as described in the Online Methods. n=5 biologically independent samples, 2-tailed t-test, t=5.21, d.f.=8, P=0.0008 (\*). (**d**) Cells from wild-type H99 (DTY758), *cuf1*∆ (DTY761), and *cuf1*∆ cells complemented with Cuf1-FLAG (DTY982) were grown in SC and treated with either 1 mM CuSO~4~ or 1 mM BCS for 3 h. Mean (± SEM) *BIM1* transcript levels were normalized to 100% in the wild-type strain, and *BIM1* expression levels in the other strains normalized to the wild-type. n=3 biologically independent samples (2 technical replicates each), 1-way ANOVA, F=86.63, d.f.=2, P\<0.0001, Fisher's LSD test was performed for multiple comparisons: WT vs *cuf1*∆ P\<0.0001 (\*\*\*\*), WT vs *cuf1*∆:*CUF1-FLAG* P = 0.084 and *cuf1*∆ vs *cuf1*∆:*CUF1-FLAG* P\<0.0001 (\*\*\*\*).](nihms-1544361-f0001){#F1}

![*C. neoformans bim1*∆ mutants have a Cu-deficiency growth phenotype.\
(**a**) Cultures of strains wild-type H99 (DTY758), *bim1*∆ (DTY1000), *ctr1*∆ (DTY765), *ctr4*∆ (DTY763), *bim1*∆ *ctr1*∆ (DTY1002), *bim1*∆ *ctr4*∆ (DTY1003), *ctr1*∆ *ctr4*∆ (DTY759) and *bim1*∆ *ctr1*∆ *ctr4*∆ (DTY1004) were serially diluted and spotted on SC agar supplemented or not with BCS. (**b**) Mean (± SEM) relative *CTR4* transcript levels in *C. neoformans* wild-type H99 (DTY758), *bim1*∆ (DTY1000), and *bim1*∆ complemented with *BIM1* (DTY1001) cells grown in YPEG medium with or without CuSO~4~. n=3 biologically independent samples (3 technical replicates each), 2-way ANOVA, F=117, d.f.=2, P\<0.0001, Fisher's LSD test was performed for multiple comparisons: P\<0.0001 (\*\*\*\*). (**c-e**) Relative cell-associated Cu concentrations \[(**c**), n=3 biologically independent samples, 1-way ANOVA, F=18.93, d.f.=2, P=0.0026, Fisher's LSD test was performed for multiple comparisons: WT *vs bim1*∆ P=0.0037 (\*\*), *bim1*∆ *vs bim1*∆:*BIM1* P = 0.0011 (\*\*), WT *vs bim1*∆:*BIM1* P=0.2630\], Cu, Zn superoxide dismutase activity \[(**d**), n=3 biologically independent samples (2 technical replicates each), 1-way ANOVA, F=13.07, d.f.=2, P=0.0065, Fisher's LSD test was performed for multiple comparisons: WT *vs bim1*∆ P=0.0025 (\*\*), *bim1*∆ vs *bim1*∆:*BIM1* P=0.0141(\*), WT *vs bim1*∆:*BIM1* P=0.1659\] and relative cell associated Fe concentrations \[(**e**), n=3 biologically independent samples, 1-way ANOVA, F=341.3, d.f.=2, P\<0.0001, Fisher's LSD test was performed for multiple comparisons: WT *vs bim1*∆ and *bim1*∆ vs *bim1*∆:*BIM1* P\<0.0001 (\*\*\*\*), WT *vs bim1*∆:*BIM1* P = 0.0013 (\*\*)\] in strains as in (b) grown in YPEG medium. (**f**) Bim1-HA co-immunoprecipitation with Ctr1-4FLAG (and [Supplementary Figure 7](#SD1){ref-type="supplementary-material"}). Protein extracts of strains *bim1*∆ complemented with Bim1-HA and expressing Ctr1-4FLAG tagged (DTY1016) and of bim1∆ expressing Ctr1-4FLAG tagged (DTY1015) were immunoprecipitated with HA-antibodies and analyzed for co-immunoprecipitation by immunoblotting with FLAG and HA antibodies. (**a**) and (**f**) were repeated independently three times with similar results.](nihms-1544361-f0002){#F2}

![*C. neoformans* Bim1 is a mannoprotein that is attached to the cell through a GPI anchor.\
(**a**) Bim1-HA subcellular fractionation (and [Supplementary Figure 8](#SD1){ref-type="supplementary-material"}). Strains *bim1*∆ complemented with Bim1-HA (DTY1005) and *bim1*∆ complemented with Bim1-HA lacking the GPI signal sequence (DTY1015), were fractionated and Bim1-HA was probed for cell-association, cell wall attachment in untreated cells or cells treated with β-glycosidase, for abundance in cell culture supernatants and for membrane partitioning in Triton X-114 solubilized extracts as indicated. These experiments were repeated independently three (subcellular fractionation) and two (membrane partitioning) times with similar results. Immunoblotting was performed with antibodies specific for HA, histone H3 or Cda2. (**b**) Bim1-HA cellular localization assessed by indirect immunofluorescence. Cultures of strains wild-type H99 (DTY758) and *bim1*∆ complemented with BIM1-HA (DTY1005) were grown in SC medium with 0.5 mM BCS for 3 h. Cells were then fixed and processed for immunofluorescence microscopy. Top lane, merged differential interference contrast and fluorescence images (MERGE), bottom lane, fluorescence images after staining with α-HA antibody conjugated to Alexa Fluor 594. This experiment was performed once. (**c**) Culture supernatants from *bim1*∆ (DTY1000), *bim1*∆ complemented with Bim1-HA (DTY1005) and *bim1*∆ complemented with Bim1-HA-∆GPI (DTY1007) cells were collected and concentrated. *bim1*∆ (DTY1000) cells grown in SC medium were diluted to OD~600~ of 0.002 and grown in the presence of the indicated concentrated supernatants in 96-well plates and with the indicated concentrations of BCS. Protein concentration was evaluated in the concentrated supernatants by immunoblotting with HA and Cda2 antibodies (inset, and [Supplementary Figure 9](#SD1){ref-type="supplementary-material"}). n=3 biologically independent samples (2 technical replicates each), 2-way ANOVA, F=6.63, d.f.=6, P=0.0003, Fisher's LSD test was performed for multiple comparisons: at 0.6 mM *BIM1-HA* vs *bim1*∆ P=0.0012 (\*\*), *bim1*∆ *vs BIM1-HA-∆GPI* P=0.0001 (\*\*\*), *BIM1-HA vs BIM1-HA-∆GPI* P=0.3804. At 1.25 mM *BIM1-HA vs bim1*∆ P=0.0010 (\*\*\*), *bim1*∆ vs *BIM1-HA-∆GPI* P\<0.0001 (\*\*\*\*), *BIM1-HA vs BIM1-HA-∆GPI* P=0.0002 (\*\*\*\*).](nihms-1544361-f0003){#F3}

![Bim1 binds Cu^2+^ via His and Asp ligands.\
(**a**) Bim1 homology structural model (cyan) aligned with the PDB structure corresponding to the *La*X325 structure (grey) used as a template, with copper shown as a sphere and coordinating residues as sticks in the Bim1 model. (**b**) Close-up view of the Cu^2+^ coordination environment in the Bim1 structural model. The His brace residues (H20 and H65) are shown in yellow, a conserved Gly rich loop, including a predicted Cu-binding Asp residue (D138), is labelled in red. The additional His64 residue mutated in this study is also shown. (**c-d**) Cell cultures of wild-type (DTY758), *bim1*∆ (DTY1000), and bim1∆ complemented with either Bim1-HA (DTY1005), Bim1-HA H20A (DTY1008), Bim1-HA H64,65A (DTY1009) and Bim1-HA D138A or D138S (DTY1023 or DTY1025) strains were grown in SC medium and spotted on SC agar supplemented or not with BCS (**c**) or spotted on a DOPA agar plate supplemented or not with CuSO~4~ for assessment of melanin production (**d**). Plates were incubated in the dark at 30°C for 2 (**c**) or 1.5 (**d**) days and photographed. (**e**) EPR spectrum of CuSO~4~ in solvent (blue line) and in the presence of purified Bim1 (red line) at the indicated concentrations. These experiments were performed independently three \[(**c**) and (**d**)\] and two times (**e**) with similar results. (**f**) Unfiltered k3-weighted extended X-ray absorption fine structure (EXAFS) spectrum (left frame, black line) and the corresponding non-phase corrected Fourier transform of the Cu^2+^ Bim1 protein (right frame, black line). Multiple scattering pathways were calculated from the active site crystallographic coordinates of an LPMO bound in a histidine brace and the Cu-His distance refines to 2.03 Å (details provided in [Supplementary Figure 5c](#SD1){ref-type="supplementary-material"}). An additional first-shell, low-Z ligand at 1.94 Å was required to best fit the data.](nihms-1544361-f0004){#F4}

![The Bim-Ctr1 Cu uptake pathway is a virulence determinant in mouse models of cryptococcal meningitis.\
(**a**) Retro-orbital infection of A/J mice with 5,000 cells of the following strains cultured in SC medium: wild-type H99 (DTY981), *bim1*∆ *ctr4*∆ (DTY1020), and *bim1*∆ *ctr4*∆ complemented with *BIM1* (DTY1021). (**b**) Retro-orbital infection of outbred CD1 mice with 5,000 cells of the following strains cultured in SC medium: wild-type H99 (DTY981), *bim1*∆ *ctr4*∆ (DTY1020), *ctr4*∆ (DTY1019) and *bim1*∆ *ctr4*∆ complemented with *BIM1* (DTY1021). (**c**) Intranasal infection of inbred A/J mice with 500,000 cells of the following strains cultured in SC: wild-type H99 (DTY981), *bim1*∆ *ctr4*∆ (DTY1020), and *bim1*∆ *ctr4*∆ complemented with *BIM1* (DTY1021). Experiments **a-c** were performed once with 5 mice infected per strain. In all experiments the survival average of mice infected with the wild-type was compared to the survival average of mice infected with any of the mutants by the two-sided log rank statistical test. In (**a**) and in (**b**) statistical differences were found between mice infected with wild-type vs mice infected with *bim1*∆ *ctr4*∆. P values are indicated in the figures.](nihms-1544361-f0005){#F5}
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